Turkish Version of Breast Edema Questionnare: Validity and Reliability Study
1 other identifier
observational
100
1 country
1
Brief Summary
This study was planned to investigate the complaint of breast edema after breast conserving surgery and radiotherapy, which are considered as the main treatment modalities for breast cancer. The incidence of breast edema after these treatments ranges from 0% to 90.4%. In contrast to arm lymphedema, which has been described in detail in the literature, only a few studies have investigated breast edema. There is no survey study that comprehensively examines the presence of lymphedema and its clinical features (duration, severity, location). Studies to assess breast edema after breast cancer treatment have revealed the need for a condition-specific scale. Therefore, the "Breast Edema Questionnaire" was developed to assess breast edema in women who have undergone breast cancer surgery. The original language of this questionnaire is German and its reliability and validity has not been studied in another language. In this study, the validity and reliability of this questionnaire, which specifically assesses breast edema, will be tested in Turkish women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2023
CompletedFirst Submitted
Initial submission to the registry
September 8, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 19, 2024
February 1, 2023
9 months
September 8, 2024
September 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Breast Edema Questionnare
Unlike arm lymphedema, which is described in detail in the literature, there are only a few studies investigating breast lymphedema after breast cancer treatment. Breast ultrasound (US) is considered to be a more reliable and quantitative measure of breast edema. However, there is no survey study that comprehensively examines these outcome measures according to the presence and clinical features of lymphedema (duration, severity, location of lymphedema). In studies conducted to evaluate breast edema after breast cancer treatment, the necessity of a situation-specific scale has emerged. For this reason, the "Breast Edema Questionnaire" was developed to evaluate breast edema in women undergoing breast cancer surgery.
one week
Secondary Outcomes (3)
Ultrasound
baseline
Moisture Meter Compact
baseline
Visual Analog Scale
baseline
Interventions
The Breast Edema Questionnaire, developed to evaluate breast edema in women undergoing breast cancer surgery, will be applied.
Eligibility Criteria
Female individuals diagnosed with breast cancer, undergoing breast conserving surgery, literate, and signed the informed consent form will be included in the study.
You may qualify if:
- Individuals with a diagnosis of breast cancer who have undergone breast-conserving surgery
- individuals who have signed the Informed Consent form
You may not qualify if:
- illiterate individuals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aysima Barlaklead
Study Sites (1)
Faculty of Physical Therapy and Rehabilitation
Ankara, Sıhhiye, 06100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PT
Study Record Dates
First Submitted
September 8, 2024
First Posted
September 19, 2024
Study Start
October 18, 2022
Primary Completion
June 30, 2023
Study Completion
September 30, 2023
Last Updated
September 19, 2024
Record last verified: 2023-02
Data Sharing
- IPD Sharing
- Will not share